Spyre Therapeutics, Inc. (SYRE)
74.05
-0.27
(-0.36%)
USD |
NASDAQ |
May 22, 16:00
73.15
-0.90
(-1.22%)
After-Hours: 20:00
Spyre Therapeutics Shareholders Equity (Quarterly) : 670.81M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 387.58M |
| Cogent Biosciences, Inc. | 607.69M |
| Revolution Medicines, Inc. | 1.500B |
| Apellis Pharmaceuticals, Inc. | 414.92M |
| Replimune Group, Inc. | 210.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 763.95M |
| Total Liabilities (Quarterly) | 93.14M |
| Current Ratio | 8.971 |